Detalles de la búsqueda
1.
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis.
Value Health
; 18(2): 173-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773552
2.
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
Health Qual Life Outcomes
; 12: 102, 2014 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24988902
3.
Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.
J Manag Care Spec Pharm
; 23(3-b Suppl): S3-S4, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28287348
4.
Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis.
J Manag Care Spec Pharm
; 23(3-b Suppl): S17-S24, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28287347
5.
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
J Manag Care Spec Pharm
; 21(5): 409-23, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25943002
6.
Validity of cost and utility results?
Pharmacoeconomics
; 30(10): 977; author reply 977-8, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22873802
Resultados
1 -
6
de 6
1
Próxima >
>>